Focus:
STA Pharmaceutical (STA), a subsidiary of WuXi AppTec, opened its new large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility in Changzhou, China, in January 2020.
In May 2019, Iovance Biotherapeutics announced its plans to build a cell therapy production facility...
Read More...
In May 2019, ILC Dover opened a manufacturing facility in Ireland to produce the company’s...
Read More...
In September 2011, the University of Saskatchewan opened a new vaccine research and development (R&D)...
Read More...
The Imaging Centre of Excellence (ICE) at the Queen Elizabeth University Hospital (QEUH) in Scotland...
Read More...
Iroko Pharmaceuticals inaugurated its new global corporate headquarters in December 2012 at Navy Yard Corporate...
Read More...
Isis Pharmaceuticals inaugurated a new research and development (R&D) facility at Carlsbad in California, USA...
Read More...
The International Stem Cell Corporation (ISCO) launched its new Oceanside stem cell manufacturing facility in...
Read More...
IDT Biologika is one of the leading biotechnology companies in Germany with its origins in...
Read More...
Indena SpA, an Italian company based in Settala near Milan, has announced plans to automate...
Read More...
IC AsiaCo Ltd (Indochina Co Ltd), a subsidiary of Indochina Pharmaceutical Co., Ltd, began construction...
Read More...
